TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the Tullett Prebon plc
underlying issuer of existing shares to
which voting rights are attached:
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which
may result in the acquisition of shares already issued to which voting
rights are attached
An acquisition or disposal of instruments with similar economic effect
to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please
specify): Transfer of assets from Lloyds Banking Group.
X
3. Full name of person(s) subject to the Lloyds Banking Group plc
notification obligation:
4. Full name of shareholder(s) (if See Section 9.
different from 3.):
5. Date of the transaction and date on 10 May 2011
which the threshold is crossed or reached:
6. Date on which issuer notified: 12 May 2011
7. Threshold(s) that is/are crossed or Direct / Indirect holdings
reached: decreased to below 12%
8. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous Resulting situation after the triggering
shares to the triggering transaction
transaction
if possible Number Number Number Number of voting % of voting
using of of of shares rights rights
the ISIN CODE Shares Voting
Rights Direct Direct Indirect Direct Indirect
Ord 25p Shares
25,876,255 25,876,255 4,057,911 4,057,911 21,711,016 1.885% 10.083%
GB00B1H0DZ51
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that may be rights
Period acquired if the
instrument is
exercised/
converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights rights
instrument period instrument
refers to
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
25,768,927 11.968%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
25,370,951 shares (11.783%) are under the control of Scottish Widows Investment
Partnership Ltd, a wholly owned subsidiary of Scottish Widows Investment
Partnership Group Ltd, a wholly owned subsidiary of Scottish Widows Group Ltd,
a wholly owned subsidiary of Lloyds TSB Bank plc, a wholly owned subsidiary of
Lloyds Banking Group plc (Direct/Indirect Interests).
Within these holdings 2,791,137 shares (1.296%) are managed on behalf
of Clerical Medical Managed Funds Limited, a wholly owned subsidiary of
Clerical Medical Investment Group Limited, a wholly owned subsidiary of HBOS
Financial Services Limited, a wholly owned subsidiary of HBOS Insurance &
Investment Group Limited, a wholly owned subsidiary of HBOS plc, a wholly owned
subsidiary of Lloyds TSB Bank plc, a wholly owned subsidiary of Lloyds Banking
Group plc. These holdings are therefore disclosed as an overall Direct
Interest.
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder N/A
will cease to hold:
12. Date on which proxy holder will cease N/A
to hold voting rights:
13. Additional information: Notification using the Total Voting
Rights figure of 215,313,584
14. Contact name: Matthew Wilson
15. Contact telephone number: 0113 235 7729
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.